Komori
Changes in Officers4512WAKAMOTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Concerning Changes in Officers

The positions and responsibilities of 3 directors will change, and 2 of them will newly become director candidates. 1 outside director who serves as an Audit and Supervisory Committee member will also be a new candidate, and 1 executive officer will take office.

Worth reading
32Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 2024年3月22日

Incoming appointee

4 items
Scheduled Appointment Date2024年6月下旬予定(取締役の就任は第129回定時株主総会の承認を経て正式決定予定)
Hirai Tomoyuki (平井 友行)
Previous position理事 経営企画室長 兼 総務部長 兼 広報室長
New position常務取締役 管理本部長 兼 経営企画室長 兼 総務部長 兼 サステナビリティ推進室長
谷口 誠
Previous position執行役員 生産本部長 兼 相模大井工場長
New position取締役 生産本部長 兼 相模大井工場長
樋川 加奈
Previous positionNot disclosed
New positionOutside Director, Audit and Supervisory Committee Member
林 博章
Previous position信頼性保証部長 兼 品質保証室長
New position執行役員 信頼性保証部長
Shareholders’ meeting approval第129回定時株主総会の承認が必要。開催日は2024年6月下旬予定This appointment will not be formally finalized until it is approved at the general meeting of shareholders.
Reasons for appointment

本日開示の「社外取締役候補者の選任のお知らせ」を参照する旨の記載のみで、選任理由自体は本書類に記載なし

Executive officers are responsible for day-to-day business execution and hold positions separate from directors under the Companies Act.“Outside” refers to directors who oversee management without having come from the company.
Who is moving to which position
ItemDetails
Resolution date2024年3月22日
Scheduled Appointment Date2024年6月下旬予定(取締役の就任は第129回定時株主総会の承認を経て正式決定予定)
Name of appointeeHirai Tomoyuki (平井 友行), 谷口 誠, 樋川 加奈, 林 博章
Appointee's new position常務取締役 管理本部長 兼 経営企画室長 兼 総務部長 兼 サステナビリティ推進室長, 取締役 生産本部長 兼 相模大井工場長, Outside Director, Audit and Supervisory Committee Member, 執行役員 信頼性保証部長
Appointee's previous position理事 経営企画室長 兼 総務部長 兼 広報室長, 執行役員 生産本部長 兼 相模大井工場長, Not disclosed, 信頼性保証部長 兼 品質保証室長
Reasons for appointment本日開示の「社外取締役候補者の選任のお知らせ」を参照する旨の記載のみで、選任理由自体は本書類に記載なし
Subject to Approval by the General Meeting of Shareholders第129回定時株主総会の承認が必要。開催日は2024年6月下旬予定
Items this document does not state (14)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No specific reason for the changes is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Changes in Officers | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) timely disclosure | Komori